أفضل ٦ صناديق استثمار مشتركة مع 0S90 / شركة سيروس للأدوية (DB)

شركة سيروس للأدوية
DE ˙ DB ˙ US87184Q2066
€ ٠٫٠٣ ↓ ؜٠٫٠٦ (؜٦٧٫٢٣%)
2025-03-26
شارك السعر
أفضل ٦ صناديق استثمار مشتركة مع DE:0S90 / Syros Pharmaceuticals, Inc.

تعرض هذه الصفحة جميع صناديق الاستثمار المشتركة التي أبلغت عن مراكزها في DE:0S90 / Syros Pharmaceuticals, Inc.. تشير الصفوف الخضراء إلى مواضع جديدة. انقر على رمز الرابط لرؤية المعاملة الكاملة تاريخ.

قم بالترقية لفتح البيانات المميزة وتصديرها إلى Excel .

تاريخ الملف المصدر المستثمر النوع متوسط السعر
(المقدّر)		 الأسهم Δ الأسهم
(%)		 القيمة المعلنة
(1000 دولار)		 Δ القيمة
(%)		 تخصيص المحفظة
(%)
2025-07-24 NP FNCMX - صندوق مؤشر فيديليتي ناسداك المركب This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value ٠ ؜١٠٠٫٠٠ ٠ ؜١٠٠٫٠٠
2025-07-24 NP FCFMX - صندوق مؤشر السوق الإجمالي لسلسلة فيديليتي This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value ٠ ؜١٠٠٫٠٠ ٠ ؜١٠٠٫٠٠
2025-07-24 NP FSKAX - صندوق مؤشر سوق الإخلاص الإجمالي This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value ٠ ؜١٠٠٫٠٠ ٠ ؜١٠٠٫٠٠
2025-05-29 NP JAFEX - إجمالي مؤشر سوق الأوراق المالية NAV ٠ ؜١٠٠٫٠٠ ٠
2025-07-24 NP FSMAX - صندوق مؤشر السوق الممتد للإخلاص This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value ٠ ؜١٠٠٫٠٠ ٠ ؜١٠٠٫٠٠
2025-05-28 NP VEXMX - أسهم مستثمري صندوق Vanguard Extended Market Index This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value ٠ ؜١٠٠٫٠٠ ٠ ؜١٠٠٫٠٠
Other Listings
US:SYRS
GB:0LC7
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Top Investors
Features
Explore
Help Center